Document:

EX-10.1

 Exhibit 10.1 

STRICTLY CONFIDENTIAL 

Execution Version 

July [●], 2019 
 Altimmune, Inc. 

910 Clopper Road, Suite 201S 
 Gaithersburg, MD 20878 

Attention: Chief Executive Officer 
  

	 	Re:	 Lock-Up Agreement 

Ladies and Gentlemen: 

1.    This Lock-up Agreement (this
“Lock-Up Agreement”) is executed in connection with the Agreement and Plan of Merger and Reorganization (the “Merger Agreement”) by and among Altimmune, Inc., a
Delaware corporation (“Parent”), Springfield Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Parent (“Merger Sub I”), Springfield Merger Sub, LLC, a Delaware limited liability company and
wholly-owned subsidiary of Parent (“Merger Sub II” and, together with Merger Sub I, the “Merger Subs”), Spitfire Pharma, Inc., a Delaware corporation (“Company”) and David Collier, solely in his
capacity as the Stockholder Representative, dated as of July 8, 2019. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Merger Agreement. 

2.    As a material condition to the willingness of, and as an inducement to, Parent and the Merger Subs to enter into the
Merger Agreement and to consummate the Transactions, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned hereby irrevocably, by executing this
Lock-Up Agreement, agrees that, during the Lock-Up Period, the undersigned will not: (a) offer, pledge, sell, contract to sell, grant any option or contract to
purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, make any short sale or otherwise transfer or dispose of, directly or indirectly, any shares of Parent Common Stock beneficially owned (as such
term is used in Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), or any other securities so owned, convertible into or exercisable or exchangeable for
Parent Common Stock, in each case, that are currently or hereafter owned of record or beneficially (including as a custodian) by the undersigned (in each case of the foregoing, solely to the extent that such shares of Parent Common Stock were issued
to the undersigned pursuant to Section 1.7 of the Merger Agreement in satisfaction of Parent’s obligations (as, when and if such obligations arise) to pay the Closing Shares (as defined below), the IND Shares (as defined below) and/or the
Phase 2 Shares (as defined below)) (collectively, the “Restricted Shares”); (b) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the
Restricted Shares, whether any such transaction described in clause (a) or (b) above is to be settled by delivery of Restricted Shares or such other securities, in cash or otherwise; (c) make any demand for, or exercise any right with
respect to, the registration of any Restricted Shares or any 

 
security convertible into or exercisable or exchangeable for Restricted Shares; or (d) publicly disclose the intention to do any of the foregoing (each of the foregoing restrictions, the
“Lock-Up Restrictions”). For purposes of this Lock-up Agreement, the “Lock-Up Period” means,
with respect to the shares of Parent Common Stock issued to the undersigned in satisfaction of the (A) Total Closing Consideration Amount and/or any Positive Adjustment Amount (the “Closing Shares”), each of (i) the period
commencing on the Closing Date to and including the date that is six (6) months following the Closing Date with respect to one-third (1/3) of the Closing Shares; (ii) the period commencing on the
Closing Date to and including the date that is twelve (12) months following the Closing Date with respect to one-third (1/3) of the Closing Shares; and (iii) the period commencing on the Closing Date
to and including the date that is eighteen (18) months following the Closing Date with respect to all remaining Closing Shares; (B) IND Milestone Consideration Amount (the “IND Shares”), each of (i) the period
commencing on the date of issuance of the IND Shares to and including the date that is three (3) months following such issuance with respect to one-half (1/2) of the IND Shares, and (ii) the period
commencing on the date of issuance of the IND Shares to and including the date that is six (6) months following such issuance with respect to all remaining IND Shares; and (C) Phase 2 Milestone Consideration Amount (the “Phase 2
Shares”), each of (i) the period commencing on the date of issuance of the Phase 2 Shares to and including the date that is three (3) months following such issuance with respect to one-half
(1/2) of the Phase 2 Shares, and (ii) the period commencing on the date of issuance of the Phase 2 Shares to and including the date that is six (6) months following such issuance with respect to all remaining Phase 2 Shares. 

The undersigned agrees that the Lock-Up Restrictions preclude the undersigned from engaging, at any
time during the Lock-Up Period, in any hedging or other transaction with respect to the Restricted Shares which is designed to or reasonably expected to lead to, or result in, a sale or disposition of the
Restricted Shares or the voting power associated therewith even if such Restricted Shares would be disposed of by someone other than the undersigned. Such prohibited hedging or other transactions would include, without limitation, any short sale
(whether or not against the box) or any purchase, sale or grant of any right (including, without limitation, any put or call option) with respect to any of the Restricted Shares or with respect to any security that includes, relates to, or derives
any significant part of its value from the Restricted Shares. 
 3.    Notwithstanding the foregoing, the restrictions
on transfer set forth in this Lock-Up Agreement shall not apply to: 
 a. transfers of the Restricted
Shares: 
  

	 	i.	 if the undersigned is a natural person, (A) to any person related to the undersigned by blood or adoption
who is an immediate family member of the undersigned, or by marriage or domestic partnership (a “Family Member”), or to a trust formed for the direct or indirect benefit of the undersigned or any of the undersigned’s Family
Members, (B) to the undersigned’s estate, legal representative, heirs or beneficiaries following the death of the undersigned, by will, intestacy or other operation of law, or (C) by operation of law pursuant to a qualified domestic
order or in connection with a divorce settlement; 

  
 2 

	 	ii.	 if the undersigned is a corporation, partnership or other business entity, (A) to another corporation,
partnership or other business entity that is an affiliate (as defined under Rule 12b-2 of the Exchange Act) of the undersigned, including investment funds or other entities under common control or management
with the undersigned or (B) as a distribution or dividend to equity holders (including, without limitation, general or limited partners and members) of the undersigned (including, without limitation, upon the liquidation and dissolution of the
undersigned pursuant to a plan of liquidation approved by the undersigned’s equity holders); 

  

	 	iii.	 as a bona fide gift to a charitable organization; 

 

	 	iv.	 if the undersigned is a trust, to any grantors or beneficiaries of the trust; or 

 

	 	v.	 with the prior written consent of Parent 

provided that, (A) in the case of any transfer or distribution pursuant to this clause (a)(i), (a)(ii) or
(a)(iv) such transfer is not for value, and (B) each donee, heir, beneficiary or other transferee or distributee shall sign and deliver to Parent a lock-up agreement in the form of this Lock-Up Agreement with respect to the shares of Parent Common Stock that have been so transferred or distributed; 

b. transactions relating to shares of Parent Common Stock or other securities, provided that such securities are acquired in open market
transactions after the Closing Date; or 
 c. the following transfers: (i) transfers at any time in connection with a tender or exchange
offer of Parent Common Stock to a third party seeking to acquire control of Parent, or a transaction as to which Parent has entered a definitive agreement (including, for the avoidance of doubt, any merger, consolidation or similar transaction
involving Parent) or publicly announced its support of which, if effected, would result in a person or entity or group of related persons or entities acquiring securities of Parent representing a majority of the voting power of all of the
outstanding securities of Parent; or (ii) transfers required by any rule, regulation, order, writ or decree of any governmental or regulatory authority or agency. 

  
 3 

 4.    Any attempted transfer in violation of this Lock-Up Agreement will be of no effect and null and void, regardless of whether the purported transferee has any actual or constructive knowledge of the transfer restrictions set forth in this Lock-Up Agreement, and will not be recorded on the share register of Parent. The undersigned also agrees and consents to the entry of stop transfer instructions with Parent’s transfer agent and registrar
against the transfer of the Restricted Shares except in compliance with the foregoing restrictions. 
 5.    The
undersigned further represents and agrees that it has not taken and will not take, directly or indirectly, any action which is designed to or which has constituted or which would reasonably be expected to cause or result in stabilization or
manipulation of the price of any security of Parent to facilitate the sale or resale of the Restricted Shares, or which has otherwise constituted or will constitute any prohibited bid for or purchase of the Restricted Shares or any related
securities. 
 6.    It is understood that, upon the first to occur of (i) the Merger Agreement being terminated in
accordance with the provisions thereof at any time prior to the Closing Date and (ii) the mutual written consent of the parties hereto, this Lock-Up Agreement shall terminate automatically, without any
notice or other action of any person. Upon termination of this Lock-Up Agreement, no party shall have any further obligations or liabilities under this Lock-Up
Agreement; provided that nothing in this Section 6 shall relieve any party from any liability for breach of this Lock-Up Agreement. 

7.    All disputes, claims or controversies arising out of or relating to this
Lock-Up Agreement, or the negotiation, execution, validity or performance of this Lock-Up Agreement, or the transactions contemplated hereby shall be governed by and
construed in accordance with the laws of the State of Delaware without regard to its rules of conflict of laws. Each party hereby irrevocably and unconditionally consents to submit to the sole and exclusive jurisdiction of the Delaware Court of
Chancery or in the event (but only in the event) that such Delaware Court of Chancery does not have subject matter jurisdiction, the United States District Court for the District of Delaware (the “Chosen Courts”) for any litigation
arising out of or relating to this Lock-Up Agreement, or the negotiation, validity or performance of this Lock-Up Agreement, or the transactions contemplated hereby (and
agrees not to commence any litigation relating thereto except in such courts), waives any objection to the laying of venue of any such litigation in the Chosen Courts and agrees not to plead or claim in any Chosen Court that such litigation brought
therein has been brought in any inconvenient forum. Each of the parties hereto agrees, (a) to the extent such party is not otherwise subject to service of process in the State of Delaware, to appoint and maintain an agent in the State of
Delaware as such party’s agent for acceptance of legal process and (b) that service of process may also be made on such party by prepaid certified mail with a proof of mailing receipt validated by the United States Postal Service
constituting evidence of valid service. Service made pursuant to clauses (a) or (b) above shall have the same legal force and effect as if served upon such party personally within the State of Delaware. EACH PARTY HEREBY
IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING, OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS LOCK-UP AGREEMENT, OR THE ACTIONS OF
THE PARTIES IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE, AND ENFORCEMENT HEREOF. 

  
 4 

 8.    This Lock-Up Agreement may
not be amended, modified, revoked or terminated in any respect without the written consent of the undersigned and Parent. 

9.    The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement and that upon request, the undersigned will execute any additional documents reasonably necessary to ensure the validity or enforcement of this Lock-Up
Agreement. 
 10.    The undersigned further understands that this Lock-Up
Agreement is irrevocable and shall be binding upon the undersigned’s heirs, legal representatives, successors and assigns. 

11.    This Lock-Up Agreement may be signed in any number of counterparts, each of
which shall be deemed an original and all of which shall constitute one and the same document. This Lock-Up Agreement may be executed by facsimile or email signatures. 

12.    All notices, requests, claims, demands and other communications under this
Lock-Up Agreement will be in writing and will be deemed given if delivered personally, sent by overnight courier (providing written proof of delivery) or via facsimile (providing written proof of
transmission), and to the undersigned at the address set forth on the signature page hereto (or at such other address for a party as specified by like notice). 

[Remainder of Page Intentionally Left Blank.] 

  
 5 

 This Lock-Up Agreement is executed as of the date
first set forth above. 
  

			
	Very truly yours,
	
	Print Name of Undersigned:
	
	  

 
			
		
	By:	 	  

 
			
	Name:	 	
	Title:	 	
		
	Address:	 	  

		
		 	  

 Acknowledged and agreed to as of 

the date written above: 
  

			
	ALTIMMUNE, INC.

			
		
	By:	 	  

			
	Name:	 	
	Title:	 	

  
 6Exhibit 4.1

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED PURSUANT TO
THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS THERE IS
A REGISTRATION STATEMENT THEN IN EFFECT COVERING SUCH SECURITIES OR AN EFFECTIVE EXEMPTION FROM SUCH REGISTRATION OR AN OPINION
OF COUNSEL SATISFACTORY TO THE COMPANY THAT UNDER THE CIRCUMSTANCES REGISTRATION IS NOT NECESSARY.

 

RESEARCH
FRONTIERS INCORPORATED

COMMON
STOCK PURCHASE WARRANT

 

THIS COMMON
STOCK PURCHASE WARRANT (THIS “WARRANT CERTIFICATE”) CERTIFIES that, for value received, GAUZY, LTD. (hereinafter
called “Warrantholder”), is entitled to purchase from Research Frontiers Incorporated, a Delaware corporation
(hereinafter called the “Company”), 362,319 shares of common stock, par value $.0001 per share (hereinafter
called the “Shares”) of the Company at a warrant exercise price equal to the Exercise Price per share (such price
per share and the number of shares of common stock so purchasable being subject to adjustment as provided below) at any time on
or before 4:30 p.m. New York time on May 31, 2024 (the “Expiration Date”), all in accordance with the terms
hereof. The “Exercise Price” per Share shall be $1,656 for warrant exercises occurring on or before May 31, 2020,
and shall be $1,794 for warrant exercises occurring from June 1, 2020 through May 31, 2021. For warrant exercises occurring after
May 31, 2021, the Exercise Price per share shall be $2.07; provided, however, that upon the occurrence of any of the events specified
in Section 2 hereof, the rights granted by this warrant, including the Exercise Price per share shall be adjusted as therein specified.

  

1.   Exercise
of Warrants and Holding of Underlying Stock.

 

1.1   This
Warrant Certificate may be exercised at any time after November 30, 2019 and prior to 4:30 p.m. New York time on the Expiration
Date in whole at any time or in part from time to time during such period by the surrender of this Warrant Certificate, along
with a Notice of Exercise in the form attached hereto duly executed and completed by Warrantholder, at the office of the Company,
240 Crossways Park Drive, Woodbury, New York 11797-2033 together with payment in full in lawful money of the United States, of
the Exercise Price per Share payable at the time of such exercise. Such payment shall be made by wire transfer of immediately
available funds to the account of Research Frontiers Incorporated at JPMorgan Chase Bank, 6040 Tarbell Road, Syracuse, New York
13206, Account Number: 880-834-155, ABA Wire Code No.: 021 000 021, SWIFT CODE: CHASUS33, or to such other account or place, as
the Company may specify. Nothwithstanding the foregoing, for as long as a registration statement covering the Shares issuable
upon exercise of this Warrant Certificate has not been being declared effective by the Commission, or an exemption from the registration
requirements of the Securities Act of 1993 for the issuance of the Shares issuable upon exercise of this Warrant Certificate does
not exist, or such Shares may not be sold by the Warrantholder pursuant to Rule 144 as determined by the counsel to the Company
pursuant to a written opinion letter to such effect, addressed and reasonably acceptable to the Company's transfer agent, then
the Warrantholder may, at its option, exercise and receive from the Company the Shares evidenced by this Warrant Certificate by
delivery of capital stock to the

 

    	 	 	 

     

    

 

Company
having a fair market value equal to the Exercise Price; or by the Warrantholder consenting to a reduction in the number of Shares
covered by this Warrant Certificate to that number of Shares which have a fair market value (on the date of exercise) equal to
the excess of the fair market value (on the date of exercise) of the Shares covered by the original unreduced Warrant Certificate
over the Exercise Price of the Shares covered by the original unreduced Warrant Certificate; or by any combination of the methods
of payment permitted above. For purposes of this paragraph, fair market value shall be determined by the Board of Directors of
the Company and, if the Shares are listed on a national securities exchange or traded on the over-the-counter market, shall be
the mean of the highest and lowest trading prices or of the high bid and low asked prices of the Shares on such exchange, or on
the over-the-counter market as reported by the National Quotation Bureau, Inc., as the case may be, on the day on which this Warrant
Certificate is exercised or, if there is no trading or bid or asked price on that day, the mean of the highest and lowest trading
or high bid and low asked prices on the most recent day preceding the day on which this Warrant Certificate is exercised for which
such prices are available. The Company shall immediately instruct its transfer agent to make delivery of such Shares, provided
that if any law or regulation requires any further action to be taken with respect to the Shares specified in such notice before
the issuance thereof, then the date of delivery of such Shares shall be extended for the period necessary to take such action.
If less than all of the underying Shares represented by this Warrant Certificate are being purchased, the Company will, upon such
exercise, deliver to Warrantholder a new certificate (dated the date hereof) representing the remaining number of Shares purchasable
hereunder. All other terms and conditions of such amended Warrant Certifiacte shall be identical to those contained herein.

 

1.2   Certificates
representing Shares issued hereunder shall be stamped or otherwise imprinted with a legend substantially in the following form
(in addition to any legend required under any applicable state securities laws):

 

THE
SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED PURSUANT TO THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT
BE SOLD, TRANSFERRED. HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS THERE IS A REGISTRATION STATEMENT THEN IN EFFECT COVERING SUCH
SHARES OR AN EFFECTIVE EXEMPTION FROM SUCH REGISTRATION OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT UNDER THE CIRCUMSTANCES
REGISTRATION IS NOT NECESSARY.

 

Provided,
however, that if the issuance of the Shares pursuant to the exercise of this Warrant Certificate are subject to an effective registration
statement pursuant to Section 5 of the Securities Act of 1933, as amended, certificates representing the Shares shall not bear
any restrictive legend.

 

2.   Reclassification.
Consolidation or Merger.

 

2.1   In
the event that the outstanding Shares are hereafter changed by reason of reorganization, merger, consolidation, recapitalization,
reclassification, stock split-up, combination or exchange of Shares and the like, or dividends payable in Shares, an appropriate
adjustment shall be made by the Board of Directors of the Company in the number of Shares and price per Share subject to this
Warrant Certificate. If the Company shall be reorganized, consolidated, or merged

 

    	 	 	 

     

    

 

with another
corporation, or if all or substantially all of the assets of the Company shall be sold or exchanged, the Warrantholder shall at
the time of issuance of the stock under such a corporate event, be entitled to receive upon the exercise of the vested Warrants
evidenced by this Warrant Certificate the same number and kind of shares of stock or the same amount of property, cash or securities
as he would have been entitled to receive upon the occurrence of any such corporate event as if he had been, immediately prior
to such event, the holder of the number of Shares so exercised.

 

2.2   Any
adjustment under this Paragraph 2 in the number of Shares subject to this Warrant Certificate shall apply proportionately to only
the unexercised portion hereunder and shall not have any retroactive effect with respect to Warrants theretofore exercised. If
fractions of a Share would result from any such adjustment, the adjustment shall be revised to the next lower whole number of
Shares.

 

2.3   No
adjustment of the exercise price shall be made if the amount of such adjustment shall be less than $.01 per Share, but in such
case any adjustment that would otherwise be required then to be made, shall be carried forward and shall be made at the time and
together with the next subsequent adjustment which, together with any adjustment so carried forward, shall amount to no less than
$.01 per share.

 

2.5   No
fractional shares of common stock shall be issued upon the exercise of this Warrant Certificate, but in lieu thereof the number
of Shares that are issuable upon any exercise shall be rounded up or down to the nearest whole Share.

 

2.6   When
any adjustment is required to be made in the exercise price or number of Shares subject to this Warrant Certificate, initial or
adjusted, the Company shall within sixty (60) days after the date when the circumstances giving rise to the adjustment occurred
mail to the Warrantholder a statement describing in reasonable detail any method used in calculating such adjustment.

 

3.   Prior
Notice as to Certain Events.

 

The
Company shall mail to Warrantholder not less than ten (10) days prior to the date on which (a) a record will be taken for the
purpose of determining the holders of Capital Stock entitled to subscription rights, or (b) a record will be taken (or in lieu
thereof, the transfer books will be closed) for the purpose of determining the holders of Capital Stock entitled to notice of
and to vote at the meeting of stockholders at which any consolidation, merger, dissolution, liquidation, winding up or sale of
the Company shall be considered and acted upon.

 

4.   Reservation
and Issuance of Shares.

 

4.1   The
Company covenants and agrees that all Shares which may be issued upon the exercise of the rights represented by this Warrant Certificate
will be duly authorized, legally issued and when paid for in accordance with the terms hereof, fully paid and non-assessable,
and free from all liens and charges with respect to the issue thereof to the Warrantholder.

 

    	 	 	 

     

    

  

4.2
The Company will reserve at all times such number of Shares as may be issuable pursuant to the exercise of Warrants evidenced
by this Warrant Certificate.

 

5.   Investment
Representation.

 

By
accepting delivery of this Warrant Certificate and by the purchase of any underlying Shares evidenced hereby, the Warrantholder
represents that the Warrantholder is acquiring the Warrant Certificate and the Shares issuable upon the exercise of the Warrant
Certificate for investment and that the Warrantholder will not offer, sell, or otherwise dispose of this Warrant Certificate or
any Shares to be issued upon exercise hereof except under circumstances that will not result in a violation of any federal, state
or foreign securities laws.

 

6.   Miscellaneous.

 

6.1   The
Warrantholder shall not be entitled to any rights whatsoever as a stockholder of the Company by virtue of its ownership of this
Warrant Certificate.

 

6.2   This
Warrant Certificate is being executed and delivered in the State of New York, and this Warrant Certificate shall be interpreted
under, and the Warrantholder and the Company subject to, the laws and jurisdiction of the state and federal courts of the State
of New York, United States of America. The parties hereby consent to such jurisdiction.

 

6.3   Subject
to the provisions of Section 1.2 hereof, this Warrant Certificate may be exercised at any time after the date hereof and prior
to its expiration as of 4:30 p.m. New York time on the Expiration Date, and shall be void and of no effect after 4:30 p.m. New
York time on the Expiration Date.

 

6.4   By
accepting delivery of this Warrant Certificate, the Warrantholder acknowledges that the Warrants granted hereunder shall be in
full satisfaction of all obligations to issue Warrants to the Warrantholder pursuant to the Subscription Agreement dated August
1, 2018 between the Company and the Warrantholder.

 

    	 	 	 

     

    

  

IN
WITNESS WHEREOF, the Company and the Warrantholder have executed this Warrant Certificate this 31st day of May, 2019 by each of
their duly authorized officers.

 

RESEARCH
FRONTIERS INCORPORATED

 

	By:	      	 
	 	Joseph M. Harary, President and CEO	 

 

240 Crossways
Park Drive

Woodbury,
NY 11797 USA

Telephone:
+1-516-364-1902

Email:
Harary@SmartGlass.com

Facsimile:
+1-516-364-3798

Attention:
Joseph M. Harary

 

WARRANTHOLDER:

 

	GAUZY, LTD.	 
	 	 	 
	By:  	/s/ Eyal Peso	 
	 	Eyal Peso, Chief Executive Officer	 

 

14 Hathiya
Street

Tel-Aviv Yafo, Israel 6816914

Telephone: +972-72-2500385

Email: Eyal@Gauzy.com

Facsimile: +972-72-2500386

Attention: Eyal Peso

 

    	 	 	 

     

    

 

[Form of
Notice of Exercise]

 

The
undersigned hereby irrevocably elects to purchase                              shares of common stock, $0.0001 par value per share,
of Research Frontiers Incorporated (the “Company”) at an exercise price of $              per share
pursuant to the attached Warrant Certificate and tenders herewith payment of the exercise price in respect thereof in full.

 

The
undersigned elects to deliver to the Company and tenders herewith US$                          representing
the aggregate exercise price for the warrants exercised hereunder.

 

Please
issue a certificate representing the said shares issuable upon exercise in the undersigned’s name.

 

The
undersigned hereby represents and warrants to the Company that the representations and warranties and acknowledgments made by
the undersigned in the Subscription Agreement dated May 30, 2019 between the undersigned and the Company are still true and correct
as if made on the date of this Notice of Exercise, and that the undersigned has carefully read any reports or statements filed
with the Securities and Exchange Commission regarding the Company after May 30, 2019, and that the Company has also made available
to the undersigned all other documents and information that the undersigned has requested relating to an investment in the Company.

 

	Dated:                       
          ,              	GAUZY, LTD.
	 	 
	 	By:	     
	 	 	Name:
	 	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}]]